Channel Dysfunction as the Basis for Comorbidities in Multiple Sclerosis and Depression
Archiv der Pharmazie · 2026-06 · 359 (6)
DOI: 10.1002/ardp.70273 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Archiv der Pharmazie, online erschienen am 09.06.2026. Verfasst von Nicole Rychlik und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, University Hospital Münster, Münster, Germany. Hauptthemen laut MEDLINE: Multiple Sclerosis, Ion Channels, Depression. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 104 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: German Research Foundation (DFG), Research Training Group 'Chemical biology of ion channels (Chembion)', Deutsche Forschungsgemeinschaft.
Themen: Depression
Abstract (Originalsprache)
Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease of the central nervous system that is frequently accompanied by major depressive symptoms, which substantially worsen disease burden and quality of life. Increasing evidence suggests that this comorbidity is not solely a psychological reaction to neurological disability but may arise from shared neurobiological mechanisms. Ion channels play a central role in regulating neuronal excitability, synaptic transmission and immune cell function, and their dysregulation has emerged as a key feature of MS pathology. Demyelination and neuroinflammation induce profound alterations in the expression, distribution and function of several ion channel families, including hyperpolarization‐activated cyclic nucleotide‐gated (HCN) channels, voltage‐gated potassium channels such as K v 7 and two‐pore domain potassium (K 2P ) channels. These changes contribute to neuronal hyperexcitability, altered thalamocortical network activity and immune cell activation. Importantly, several ion channel systems implicated in MS are also associated with affective regulation, including TRPA1, ASIC1a, N ‐methyl‐ d ‐aspartate receptors and serotonin 5‐HT3 receptors. This review summarizes current evidence linking ion channel dysfunction to both MS pathology and depression and highlights emerging pharmacological strategies targeting these channels. Understanding ion channel‐mediated mechanisms may provide novel therapeutic opportunities to address both neuroinflammation and neuropsychiatric comorbidities in MS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Neurology, University Hospital Münster, Münster, Germany.
- Institute of Physiology I, University of Münster, Münster, Germany.
ORCID-Profile: Thomas Budde, Marta Méndez-Couz
Förderung
- German Research Foundation (DFG)
- Research Training Group 'Chemical biology of ion channels (Chembion)'
- Deutsche Forschungsgemeinschaft
Zitieren
APA
Rychlik, N., Jüngling, K., Meuth, S. G., Budde, T., & Méndez-Couz, M. (2026). Channel Dysfunction as the Basis for Comorbidities in Multiple Sclerosis and Depression. Archiv der Pharmazie, 359(6). https://doi.org/10.1002/ardp.70273
Vancouver
Rychlik N, Jüngling K, Meuth SG, Budde T, Méndez-Couz M. Channel Dysfunction as the Basis for Comorbidities in Multiple Sclerosis and Depression. Archiv der Pharmazie. 2026;359(6). doi:10.1002/ardp.70273
BibTeX
@article{Rychlik2026,
author = {Rychlik, Nicole and Jüngling, Kay and Meuth, Sven G and Budde, Thomas and Méndez-Couz, Marta},
title = {Channel Dysfunction as the Basis for Comorbidities in Multiple Sclerosis and Depression},
journal = {Archiv der Pharmazie},
year = {2026},
volume = {359},
number = {6},
doi = {10.1002/ardp.70273}
}
EUVIMED